Answers are grounded in this paper and cite their sources.
Review summarizes screening and management strategies for Barrett's esophagus, suggesting improved outcomes through early detection.
Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma, which is associated with poor survival when diagnosed at advanced stages. Early detection and treatment of dysplasia improve outcomes. This review summarizes current strategies for BE screening, surveillance, and management, emphasizing advances in endoscopic diagnosis and therapy. Risk-based screening with esophagogastroduodenoscopy and systematic biopsies remains the diagnostic standard, while emerging nonendoscopic cell collection devices with biomarker assays may expand screening. Management is guided by histologic grade, with surveillance recommended for nondysplastic BE and endoscopic eradication therapy recommended for dysplasia and early neoplasia. Endoscopic resection combined with ablation achieves durable eradication with esophageal preservation.
No takes yet. Share an insight, caveat, or question.
Rajagopal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: